Met Life Investment Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 24,085 shares of MIRM stock, worth $982,667. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,085
Previous 22,729
5.97%
Holding current value
$982,667
Previous $886,000
12.3%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding MIRM
# of Institutions
214Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$268 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$187 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$132 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$114 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$106 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.5B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...